• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF2265
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Vascular Dissection (3160)
Date of Event 12/23/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A1: no patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
The following was reported to gore: on (b)(6) 2025, the patient underwent an endovascular treatment for a thoracic arch aortic aneurysm using gore® tag® conformable thoracic stent graft with active control system devices, gore® viabahn® endoprosthesis with heparin bioactive surface and gore® excluder® iliac branch endoprosthesis (ribs procedure).After two gore® tag® conformable thoracic stent graft with active control system devices were advanced through a gore® dryseal flex introducer sheath and implanted, the blood pressure dropped.Upon performing an angiography of the descending aorta, a dissection was identified at the distal tortuous segment of the descending aorta.A non-gore stent graft and a non-gore petticoat device were implanted to cover the dissection.Afterwards, the blood pressure became stable.The patient tolerated the procedure.The physician stated that there was resistance at the site where the dissection was identified when the gore® dryseal flex introducer sheath was inserted.The physician also stated that an angiography performed before the gore® tag® conformable thoracic stent graft with active control system devices were implanted was re-reviewed, and it revealed the retrograde dissection.The physician further stated that the gore® tag® conformable thoracic stent graft with active control system devices were implanted from zone 0, and that the blood pressure dropped because the dissection extended distally and the true lumen was narrowed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® DRYSEAL FLEX INTRODUCER SHEATH
Common Device Name
INTRODUCER, CATHETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
asami aizawa
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key24091321
Report Number3007284313-2026-04522
Device Sequence Number18759089
Product Code DYB
UDI-Device Identifier00733132628384
UDI-Public(01)00733132628384(17)280901
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K160254
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberDSF2265
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/23/2025
Initial Report FDA Received Date01/16/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/02/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-